0ZM Stock Overview Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. More details
Rewards Risk Analysis No risks detected for 0ZM from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Hamilton Thorne Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Hamilton Thorne Historical stock prices Current Share Price CA$1.54 52 Week High CA$1.54 52 Week Low CA$0.77 Beta 0.41 1 Month Change 6.21% 3 Month Change 10.00% 1 Year Change 101.31% 3 Year Change 8.45% 5 Year Change 120.00% Change since IPO 222.18%
Recent News & Updates Astorg Completes Take Private of Hamilton Thorne Dec 03
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Nov 30
Third quarter 2024 earnings released: US$0.008 loss per share (vs US$0.005 loss in 3Q 2023) Nov 17
Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.003 loss in 2Q 2023) Aug 15
Hamilton Thorne Ltd. to Report Q2, 2024 Results on Aug 14, 2024 Aug 07 Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. entered into a definitive arrangement agreement to acquire Hamilton Thorne Ltd (TSX: HTL) from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others in an equity reinvestment transaction for approximately CAD 350 million. Jul 22
See more updates Astorg Completes Take Private of Hamilton Thorne Dec 03
Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. completed the acquisition of Hamilton Thorne Ltd (TSX: HTL) (the "Company") from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others. Nov 30
Third quarter 2024 earnings released: US$0.008 loss per share (vs US$0.005 loss in 3Q 2023) Nov 17
Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.003 loss in 2Q 2023) Aug 15
Hamilton Thorne Ltd. to Report Q2, 2024 Results on Aug 14, 2024 Aug 07 Astorg Asset Management S A.R.L., Daniel Thorne and FAX Capital Corp. entered into a definitive arrangement agreement to acquire Hamilton Thorne Ltd (TSX: HTL) from FAX Capital Corp., Special Situations Life Sciences Fund, L.P managed by AWM Investment Company Inc, Daniel Thorne and others in an equity reinvestment transaction for approximately CAD 350 million. Jul 22
First quarter 2024 earnings released: US$0.006 loss per share (vs US$0.001 profit in 1Q 2023) May 16
Hamilton Thorne Ltd. to Report Q1, 2024 Results on May 14, 2024 May 08
Hamilton Thorne Ltd., Annual General Meeting, Jun 11, 2024 Apr 13
Full year 2023 earnings released: US$0.004 loss per share (vs US$0.013 profit in FY 2022) Mar 27
Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024 Mar 27
Hamilton Thorne Ltd. to Report Q4, 2023 Results on Mar 27, 2024 Mar 22 Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024
New major risk - Revenue and earnings growth Nov 14
Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.001 profit in 3Q 2022) Nov 14
Hamilton Thorne Ltd. to Report Q3, 2023 Results on Nov 13, 2023 Nov 08
Hamilton Thorne Ltd. (TSX:HTL) agreed to acquire Gynetics Medical Products N.V. for an enterprise value of €18.3 million. Oct 12
New minor risk - Shareholder dilution Oct 11 Hamilton Thorne Ltd.(TSXV:HTL) dropped from S&P/TSX Venture Composite Index Sep 07
Second quarter 2023 earnings released: US$0.003 loss per share (vs US$0.002 profit in 2Q 2022) Aug 18
Hamilton Thorne Ltd. to Report Q2, 2023 Results on Aug 17, 2023 Aug 11
New minor risk - Share price stability Aug 06
First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.004 in 1Q 2022) May 16
Now 20% undervalued May 12
Hamilton Thorne Ltd. to Report Q1, 2023 Results on May 15, 2023 May 09
Now 20% undervalued Apr 21
Chair, President & CEO recently sold €69k worth of stock Apr 16
Now 21% undervalued after recent price drop Apr 03
Full year 2022 earnings released: EPS: US$0.013 (vs US$0.017 in FY 2021) Mar 31
Now 21% undervalued Feb 23
Now 24% undervalued after recent price drop Feb 04
Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer Jan 25
Now 22% undervalued after recent price drop Jan 14
Hamilton Thorne Ltd. (TSXV:HTL) agreed to acquire Microptic, S.L. Dec 02
Third quarter 2022 earnings released: EPS: US$0.001 (vs US$0.002 in 3Q 2021) Nov 23
Hamilton Thorne Ltd. Provides Sales Guidance for the Year 2022 Nov 23
High number of new directors Nov 16
Hamilton Thorne Ltd. to Report Nine Months, 2022 Results on Nov 22, 2022 Nov 09
Second quarter 2022 earnings released: EPS: US$0.002 (vs US$0.003 in 2Q 2021) Aug 24
Hamilton Thorne Ltd. to Report Q2, 2022 Results on Aug 23, 2022 Aug 17
Hamilton Thorne Ltd. Announces CFO Changes Jul 13
First quarter 2022 earnings released: EPS: US$0.004 (vs US$0.006 in 1Q 2021) May 20
Hamilton Thorne Ltd. to Report Q1, 2022 Results on May 19, 2022 May 12
High number of new directors Apr 27
Hamilton Thorne Ltd., Annual General Meeting, Jun 14, 2022 Apr 16
Full year 2021 earnings released: EPS: US$0.017 (vs US$0.007 in FY 2020) Apr 08
Hamilton Thorne Ltd. to Report Q4, 2021 Results on Apr 07, 2022 Apr 01
High number of new directors Feb 08
President recently bought €52k worth of stock Dec 25
President recently sold €440k worth of stock Dec 05
Third quarter 2021 earnings: EPS in line with expectations, revenues disappoint Nov 23
Investor sentiment improved over the past week Oct 14
Second quarter 2021 earnings released: EPS US$0.003 (vs US$0.004 loss in 2Q 2020) Aug 21
Hamilton Thorne Ltd. (TSXV:HTL) acquired IVFTECH ApS and K4 Technology ApS for an enterprise value of approximately DKK 50 million ($8 million). Jul 16
First quarter 2021 earnings released: EPS US$0.006 (vs US$0.001 in 1Q 2020) May 27
Independent Director recently bought €71k worth of stock Apr 18
Full year 2020 earnings released: EPS US$0.007 (vs US$0.006 in FY 2019) Apr 10
Hamilton Thorne Ltd. Announces Board Changes Feb 10
Hamilton Thorne Announces Board Changes Jan 20
Third quarter 2020 earnings released: EPS US$0.003 Nov 20
Revenue beats expectations Nov 20
Hamilton Thorne Ltd. to Report Q3, 2020 Results on Nov 19, 2020 Nov 13
New 90-day high: €0.92 Oct 26
President recently sold €176k worth of stock Sep 28
New 90-day high - €0.91 Aug 25
Earnings released Aug 22
Hamilton Thorne Ltd. to Report Q2, 2020 Results on Aug 20, 2020 Aug 14
New 90-day high - €0.86 Jul 22 Shareholder Returns 0ZM DE Medical Equipment DE Market 7D 2.7% -0.6% -0.2% 1Y 101.3% -8.4% 7.0%
See full shareholder returns
Return vs Market: 0ZM exceeded the German Market which returned 7.9% over the past year.
Price Volatility Is 0ZM's price volatile compared to industry and market? 0ZM volatility 0ZM Average Weekly Movement 2.8% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.9% 10% most volatile stocks in DE Market 11.7% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 0ZM has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 0ZM's weekly volatility has decreased from 9% to 3% over the past year.
About the Company Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Show more Hamilton Thorne Ltd. Fundamentals Summary How do Hamilton Thorne's earnings and revenue compare to its market cap? 0ZM fundamental statistics Market cap €233.07m Earnings (TTM ) -€1.98m Revenue (TTM ) €72.10m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0ZM income statement (TTM ) Revenue US$76.30m Cost of Revenue US$37.45m Gross Profit US$38.85m Other Expenses US$40.94m Earnings -US$2.09m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.014 Gross Margin 50.92% Net Profit Margin -2.74% Debt/Equity Ratio 29.9%
How did 0ZM perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/11/29 18:54 End of Day Share Price 2024/11/29 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Hamilton Thorne Ltd. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jim Byrne Acumen Capital Finance Partners Limited Doug Cooper Beacon Securities Limited Kyle Bauser Colliers Securities
Show 7 more analysts 
